Essential reading for the healthcare business
Remember me:
Skip Navigation LinksHealthInvestor article
Virgin Care successfully forces Hull CCG to run full primary care tender

Virgin Care’s legal challenge against Hull Clinical Commissioning Group’s (CCG) proposed plans to create large-scale GP practice groups, based on geographical location, has been successful.

Hull CCG had intended to create the large-scale primary care providers by inviting groups of GPs to take over eight practices currently run under alternative provider medical services (APMS) contracts.

Three of these eight contracts, which are all due to expire in March, are run by Richard Branson-owned Virgin Care, which challenged the CCG’s plans according to HSJ.

Now, the private provider’s move has forced commissioners to undertake a full procurement process for these eight primary care practices, divided into four lots.

A report made to Hull City Council’s health overview and scrutiny committee said: “NHS England and the CCG were originally planning to invite applications from existing primary medical care providers, or existing primary medical care providers working collaboratively, who hold either a general medical services or a personal medical services contract in the city, to provide a full range of primary medical care services from the current APMS locations with the current eight contracts being grouped into four lots.

“However, following a legal challenge, NHS England and the CCG will be undertaking a full procurement, in four lots, for the future provision of the primary medical care services currently provided through the APMS contracts.”

A spokesperson for Virgin Care: “We launched the East Park, Story Street and Northpoint Medical Practice services in 2010 and since then we’ve had great feedback from the community and from our registered patients with more than 85% of people rating the service saying they’d choose to recommend the services last year. We look forward to having the opportunity to continue to provide these services in the future.”

Related articles:

Posted on: 16/02/2016

Latest news stories

Private equity house Livingbridge is on the verge of acquiring a 30% stake in home care provider Helping Hands, HealthInvestor UK understands.
Around 1.3 million NHS employees are in line for a pay increase of 6.5% or more over three years, it has been confirmed.
Auckland-based ehealth software company Orion Health has been commissioned by the four health boards in the North of Scotland – NHS Highland, NHS Grampian, NHS Orkney and NHS Shetland – a to build a new web-based portal.
Jeremy Hunt has indicated that a cap on social care costs paid by individuals may be pending, after saying that dementia sufferers should not be hit by ‘punitive’ costs.
Group operating profit fell 6% at Mears Group to £39.2 million, compared with £41.9 million in 2016, the results for the year to 31 December 2017 show.


Christie + Co

my images

interview: Adrian Stevensen
One Healthcare CEO Adrian Stevensen tells Ploy Radford how the new provider is overcoming the barriers to entry in the UK private hospital market
Read more

private finance initiative

The collapse of Carillion may have scuppered PF2's chances of survival. Mark Hellowell investigates
Read more

HealthInvestor blog
Spire’s new boss has unveiled his plans to restore the hospital group’s ailing fortunes and share price

Click here to view the Editor's blog

... is a problem halved? Clare Connell and Ryan Perrott analyse whether the Shared Lives scheme is the most effective method for moving more care into the community
Pauline Issard recounts how she harnessed technology to combat frustrations with equine health issues
BGF has backed a one-of-a-kind business bridging the gap between hospitals with blocked beds and social care providers
A new IVF clinic from the team behind CREATE Fertility plans to make treatment more affordable, transparent and accessible, with a ‘shoebox’ technique at its core. Sarah Williams speaks to abc ivf chief executive Praful Nargund
The collapse of Carillion may have scuppered PF2’s chances of survival. Mark Hellowell investigates

Click here to search all feature articles